Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Toxicogenetic analysis of Δ9-THC-metabolizing enzymes.

International journal of legal medicine - 1 Nov 2020

Gasse Angela, Vennemann Marielle, Köhler Helga, Schürenkamp Jennifer

Abstract excerpt

While the impact of genetic polymorphisms on the metabolism of various pharmaceuticals is well known, more data are needed to better understand the specific influence of pharmacogenetics on the metabolism of delta 9-tetrahydocannabinol (Δ9-THC). Therefore, the aim of the study was to analyze the potential impact of variations in genes coding for phase I enzymes of the Δ9-THC metabolism. First, a multiplex assay...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Germany
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C19

Share to Cytochrome P-450 CYP2C9

Share to Gene Frequency

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 32712703
DOI: 10.1007/s00414-020-02380-3
PMCID: PMC7578149

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Toxicogenetic analysis of Δ9-THC-metabolizing enzymes.PMID 32712703Read ↗

Assessing the influence of CYP2C9 and CYP2C19 genotypes on the metabolism of CBD-cannabis after controlled single and repetitive consumption.Semantic proximity Read ↗

Predicted Net Effects of Drug-Gene Interactions on Levels of Tetrahydrocannabinol and CannabidiolSemantic proximity Read ↗

Cytochrome P450–catalyzed hydroxylation of Δ8-tetrahydrocannabinol and implications for pharmacogeneticsSemantic proximity Read ↗

Pharmacogenetics of CannabinoidsSemantic proximity Read ↗

Interindividual variation in the pharmacokinetics of Delta9-tetrahydrocannabinol as related to genetic polymorphisms in CYP2C9.Semantic proximity Read ↗

Genomic Variation Predicts Real-Time Δ <sup>9</sup> -tetrahydrocannabinol Response in HumansSemantic proximity Read ↗

Genotype-Specific Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteers.Semantic proximity Read ↗

Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects.Semantic proximity Read ↗

Pitfalls and challenges associated with phenoconversion in forensic toxcicology.Semantic proximity Read ↗

Cytochrome P450 1B1 and 2C9 genotypes and risk of ischemic vascular disease, cancer, and chronic obstructive pulmonary disease.Semantic proximity Read ↗

Toxicogenetics--cytochrome P450 microarray analysis in forensic cases focusing on morphine/codeine and diazepam.Semantic proximity Read ↗

CYP2C19 genetics in fatal carisoprodol intoxications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.